Wine and health: State of proofs and research needs

Inflammopharmacology

Volumn 16, Issue 6, 2008, Pages 265-271

  Walzem, R L ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Alcohol; Cardiovascular disease; Health; Inflammation; Lipids; Polyphenols; Wine

Indexed keywords

ALCOHOL; ANTHOCYANIN; GALLIC ACID; HYDROXYTYROSOL; LOW DENSITY LIPOPROTEIN; POLYPHENOL; RESVERATROL;

ALCOHOL CONSUMPTION; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; WINE;

ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; FLAVONOIDS; HEALTH; HUMANS; PHENOLS; WINE;

EID: 58149117407     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-008-8027-6     Document Type: Review

References (77)

1. Addolorato, G., Leggio, L., Ojetti, V. et al. (2008). Effects of short-term moderate alcohol administration on oxidative stress and nutritional status in healthy males, Appetite 50, 50-6.
2. Arnous, A., Makris, D. P., Kefalas, P. (2001). Effect of principal polyphenolic components in relation to antioxidant characteristics of aged red wines, J Agric Food Chem 49, 5736-42.
3. Artaud-Wild, S. M., Connor, S. L., Sexton, G. et al. (1993). Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox, Circulation 88, 2771-9.
4. Avellone, G., Di Garbo, V., Campisi, D. et al. (2006). Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis, Eur J Clin Nutr 60, 41-7.
5. Basu-Modak, S., Gordon, M. J., Dobson, L. H. et al. (2003). Epicatechin and its methylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts, Free Radic Biol Med 35, 910-21.
6. Beilin, L. J. and Puddey, I. B. (2006). Alcohol and hypertension: an update, Hypertension 47, 1035-8.
7. Bell, J. R., Donovan, J. L., Wong, R., et al. (2000). (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine, Am J Clin Nutr 71, 103-8.
8. Berliner, J. A., Navab, M., Drake, T. A. et al. (1992). Do dietary fatty acids cause endothelial activation? How might endothelial activation contribute to thrombogenesis?, Am J Clin Nutr 56, 804 S.
9. Boselli, E., Boulton, R. B., Thorngate, J. H. et al. (2004). Chemical and sensory characterization of DOC red wines from Marche (Italy) related to vintage and grape cultivars, J Agric Food Chem 52, 3843-54.
10. Brenna, O. V. and Pagliarini, E. (2001). Multivariate analysis of antioxidant power and polyphenolic composition in red wines, J Agric Food Chem 49, 4841-4.
11. Brouillard, R., Chassaing, S., Fougerousse, A. (2003). Why are grape/fresh wine anthocyanins so simple and why is it that red wine color lasts so long?, Phytochemistry 64, 1179-86.
12. Brouillard, R., George, F., Fougerousse, A. (1997). Polyphenols produced during red wine ageing, Biofactors 6, 403-10.
13. Burke, V., Lee, A. H., Hunter, E. et al. (2007). Alcohol intake and incidence of coronary disease in Australian aborigines, Alcohol Alcohol 42, 119-24.
14. Burns, J., Gardner, P. T., Matthews, D., et al. (2001). Extraction of phenolics and changes in antioxidant activity of red wines during vinification, J Agric Food Chem 49, 5797-808.
15. Ceriello, A., Bortolotti, N., Motz, E., et al. (2001). Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes, Eur J Clin Invest 31, 322-328.
16. Corder, R., Mullen, W., Khan, N. Q. et al. (2006). Oenology: red wine procyanidins and vascular health, Nature 444, 566.
17. Darias-Martin, J., Martin-Luis, B., Carrillo-Lopez, M. et al. (2002). Effect of caffeic acid on the color of red wine, J Agric Food Chem 50, 2062-7.
18. de la Torre, R., Covas, M. I., Pujadas, M. A. et al. (2006). Is dopamine behind the health benefits of red wine?, Eur J Nutr 45, 307-10.
19. Demrow, H. S., Slane, P. R. and Folts, J. D. (1995). Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries, Circulation 91, 1182-8.
20. Donovan, J. L., Bell, J. R., Kasim-Karakas, S. et al. (1999). Catechin is present as metabolites in human plasma after consumption of red wine, J Nutr 129, 1662-8.
21. Donovan, J. L., Kasim-Karakas, S., German, J. B. et al. (2002). Urinary excretion of catechin metabolites by human subjects after red wine consumption, Br J Nutr 87, 31-7.
22. Frankel, E., Waterhouse, A. and Teissedre, P. (1995). Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins., J Agric Food Chem 43, 890-894.
23. Frankel, E. N., Kanner, J., German, J. B. et al. (1993). Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine, Lancet 341, 454-7.
24. Freedman, J. E., Parker, C., 3rd, Li, L. et al. (2001). Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release, Circulation 103, 2792-8.
25. Fuchs, F. D. (2005). Vascular effects of alcoholic beverages: is it only alcohol that matters?, Hypertension 45, 851-2.
26. Fuchs, F. D., Chambless, L. E., Folsom, A. R. et al. (2004). Association between alcoholic beverage consumption and incidence of coronary heart disease in whites and blacks: the Atherosclerosis Risk in Communities Study., Am J Epidemiol 160, 455-472.
27. Fuhrman, B., Volkova, N., Suraski, A. et al. (2001). White wine with red wine-like properties: increased extraction of grape skin polyphenols improves the antioxidant capacity of the derived white wine, J Agric Food Chem 49, 3164-8.
28. German, J. B. and Walzem, R. L. (2000). The health benefits of wine, Annu Rev Nutr 20, 561-93.
29. Imhof, A., Woodward, M., Doering, A. et al. (2004). Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille), Eur Heart J 25, 2092-100.
30. Johansen, K. M., Skorpe, S., Olsen, J. O. et al. (1999). The effect of red wine on the fibrinolytic system and the cellular activation reactions before and after exercise, Thromb Res 96, 355-63.
31. Joscelyne, V. L., Downey, M. O., Mazza, M. et al. (2007). Partial shading of Cabernet Sauvignon and Shiraz vines altered wine color and mouthfeel attributes, but increased exposure had little impact, J Agric Food Chem 55, 10888-96.
32. Koppes, L. L. J., Dekker, J. M., Hendriks, H. F. J. et al. (2006). Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients, Diabetologica 49, 648-652.
33. Kozarevic, D., Vojvodic, N., Gordon, T. et al. (1983). Drinking habits and death. The Yugoslavia cardiovascular disease study, Int J Epidemiol 12, 145-50.
34. Langer, R. D., Criqui, M. H., Reed, D. M. (1992). Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease, Circulation 85, 910-5.
35. Lesschaeve, I. and Noble, A. C. (2005). Polyphenols: factors influencing their sensory properties and their effects on food and beverage preferences, Am J Clin Nutr 81, 330S-335S.
36. Lopez-Velez, M., Martinez-Martinez, F., Del Valle-Ribes, C. (2003). The study of phenolic compounds as natural antioxidants in wine, Crit Rev Food Sci Nutr 43, 233-44.
37. Manach, C. and Donovan, J. L. (2004). Pharmacokinetics and metabolism of dietary flavonoids in humans, Free Radic Res 38, 771-85.
38. Manach, C., Morand, C., Crespy, V. et al. (1998). Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties, FEBS Lett 426, 331-6.
39. Marfella, R., Cacciapuoti, F., Siniscalchi, M. et al. (2006). Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus, Diabet Med 23, 974-81.
40. Meagher, E. A., Barry, O. P., Burke, A. et al. (1999). Alcohol-induced generation of lipid peroxidation products in humans, J Clin Invest 104, 805-13.
41. Moore, R. D. and Pearson, T. A. (1986). Moderate alcohol consumption and coronary artery disease. A review, Medicine (Baltimore) 65, 242-67.
42. Mukamal, K. J., Chiuve, S. E., Rimm, E. B. (2006). Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles, Arch Intern Med 166, 2145-50.
43. Orgogozo, J. M., Dartigues, J. F., Lafont, S. et al. (1997). Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area, Rev Neurol (Paris) 153, 185-92.
44. Osman, H. E., Maalej, N., Shanmuganayagam, D. et al. (1998). Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys, J Nutr 128, 2307-12.
45. Packard, R. R. and Libby, P. (2008). Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction, Clin Chem 54, 24-38.
46. Panza, F., D'Introno, A., Colacicco, A. M. et al. (2005). Current epidemiology of mild cognitive impairment and other predementia syndromes, Am J Geriat Psychiatry 13, 633-644.
47. Pignatelli, P., Pulcinelli, F. M., Celestini, A. et al. (2000). The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide, Am J Clin Nutr 72, 1150-5.
48. Ramassamy, C. (2006). Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets, Eur J Pharmacol 545, 51-64.
49. Renaud, S. and de Lorgeril, M. (1992). Wine, alcohol, platelets, and the French paradox for coronary heart disease, Lancet 339, 1523-6.
50. Renaud, S., Lanzmann-Petithory, D., Gueguen, R. et al. (2004). Alcohol and mortality from all causes, Biol Res 37, 183-7.
51. Retterstol, L., Berge, K. E., Braaten, O. et al. (2005). A daily glass of red wine: does it affect markers of inflammation? Alcohol 40, 102-5.
52. Rimm, E. B., Giovannucci, E. L., Willett, W. C. et al. (1991). Prospective study of alcohol consumption and risk of coronary disease in men, Lancet 338, 464-8.
53. Ross, R. (1999). Atherosclerosis - an inflammatory disease, N Engl J Med 340, 115-6.
54. Ruf, J. C. (1999). Wine and polyphenols related to platelet aggregation and atherothrombosis, Drugs Exp Clin Res 25, 125-31.
55. Ruf, J. C. (2004). Alcohol, wine and platelet function, Biol Res 37, 209-15.
56. Ruf, J. C., Berger, J. L., Renaud, S. (1995). Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation, Arterioscler Thromb Vasc Biol 15, 140-4.
57. Ruidavets, J., Teissedre, P., Ferrieres, J. et al. (2000). Catechin in the Mediterranean diet: vegetable, fruit or wine?, Atherosclerosis 153, 107-17.
58. Rupasinghe, H. and Clegg, S. (2007). Total antioxidant capacity, total phenolic content, mineral elements, and histamine concentrations in wines of different fruit sources., J Food Comp Anal 20, 133-137.
59. Russo, P., Tedesco, I., Russo, M. et al. (2001). Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation, Nutr Metab Cardiovasc Dis 11, 25-9.
60. Sacanella, E., Vazquez-Agell, M., Mena, M. P. et al. (2007). Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial, Am J Clin Nutr 86, 1463-9.
61. Sanchez-Moreno, C., Satue-Gracia, M. T., Frankel, E. N. (2000). Antioxidant activity of selected Spanish wines in corn oil emulsions, J Agric Food Chem 48, 5581-7.
62. Simopoulos, A. P. (2001). n-3 fatty acids and human health: defining strategies for public policy, Lipids 36, S83-9.
63. Solfrizzi, V., D'Introno, A., Colacicco, A. M. et al. (2007). Alcohol consumption, mild cognitive impairment, and progression to dementia, 68, 1790-9.
64. Solfrizzi, V., Panza, F., Colacicco, A. M. et al. (2004). Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63, 1882-1891.
65. Spencer, J. P., Schroeter, H., Crossthwaithe, A. J. et al. (2001). Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts, Free Radic Biol Med 31, 1139-46.
66. Spencer, J. P., Schroeter, H., Kuhnle, G. et al. (2001). Epicatechin and its in vivo metabolite, 3'-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation, Biochem J 354, 493-500.
67. St. Leger, A. S., Chochrane, A. L. and Moore, F. (1979). Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 12, 1017-1020.
68. van de Wiel, A., van Golde, P. M., Kraaijenhagen, R. J. et al. (2001). Acute inhibitory effect of alcohol on fibrinolysis, Eur J Clin Invest 31, 164-70.
69. Vazquez-Agell, M., Sacanella, E., Tobias, E. et al. (2007). Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk, J Nutr 137, 2279-84.
70. Vitaglione, P., Sforza, S., Galaverna, G. et al. (2005). Bioavailability of trans-resveratrol from red wine in humans, Mol Nutr Food Res 49, 495-504.
71. Walzem, R. and German, J., Eds. (2004). The French Paradox: Mechanisms of action of non-alcoholic wine components on cardiovascular disease. Beverages in Nutrition and Health. Totowa, NJ, Humana Press.
72. Walzem, R. L., Watkins, S., Frankel, E. N. et al. (1995). Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease, Proc Natl Acad Sci U S A 92, 7460-4.
73. Waterhouse, A. L. (2002). Wine phenolics, Ann N Y Acad Sci 957, 21-36.
74. Waterhouse, A. L. and Walzem, R. L. (1998). Nutrition of grape phenolics. Flavonoids in Health and Disease. C. A. Rice-Evans and L. Packer. New York, Marcel Dekker, Inc. 7, 359-385.
75. Wenzel, E. and Somoza, V. (2005). Metabolism and bioavailability of trans-resveratrol, Mol Nutr Food Res 49, 472-81.
76. Yu, J., Smith, G., Gross, H. B. et al. (2006). Enzymatic O-methylation of flavanols changes lag time, propagation rate, and total oxidation during in vitro model triacylglycerol-rich lipoprotein oxidation, J Agric Food Chem 54, 8403-8.
77. Zilkens, R. R., Burke, V., Hodgson, J. M. et al. (2005). Red wine and beer elevate blood pressure in normotensive men, Hypertension 45, 874-9.